Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial

作者：Wen Guo, Wenjun Tian, Lu Lin, Xiangjin Xu · 发表于：Diabetes Research and Clinical Practice · 年份：2020 · DOI：10.1016/j.diabres.2020.108487 · 被引用次数：123 · 研究领域：Liver Disease Diagnosis and Treatment、Diabetes, Cardiovascular Risks, and Lipoproteins、Diabetes Treatment and Management